AbCellera Biologics Inc.

An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.

ABCL | NDAQ

Overview

Corporate Details

ISIN(s):: CA00288U1066
LEI:
Country:: United States of America
Address:: 150 W 4TH AVENUE, VANCOUVER
Website:: https://www.abcellera.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, AI-powered drug discovery platform that integrates advanced technologies in biology, computation, and engineering. This full-stack platform is designed to search, decode, and analyze natural immune systems at high speed and scale to find novel antibodies for therapeutic development. AbCellera partners with pharmaceutical and biotech companies to advance a pipeline of first-in-class and best-in-class antibody programs across various therapeutic areas, including cancer and endocrinology. The platform supports the development of complex modalities, such as bispecifics and antibody-drug conjugates, for conditions with high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AbCellera Biologics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbCellera Biologics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for AbCellera Biologics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Eezy Oyj HR services firm for the full employment lifecycle, from recruitment to freelancer support.	Finland	EEZY
Elicio Therapeutics, Inc. Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.	United States of America	ELTX
enCore Energy Corp. American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.	United States of America	EU
ENERGY FUELS INC A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.	United States of America	UUUU
ENIGMATIG LTD Global expansion and regulatory compliance consultancy for the financial services industry.	United States of America	EGG
Enjin Co., Ltd. PR firm for SMEs and medical institutions, offering consulting and a media matching platform.	Japan	7370
Ensol Biosciences Inc. Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.	South Korea	140610
Enveric Biosciences, Inc. Develops novel neuroplastogen drugs for severe mental health and addiction disorders.	United States of America	ENVB
Eutilex Co.,Ltd. Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.	South Korea	263050
Evaxion A/S Develops AI-powered, personalized vaccines for cancer and infectious diseases.	United States of America	EVAX